Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
The highly-anticipated fifth edition is here! Get the must-have resource for achieving compliance with medical device regulations.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 03 June 2013 | By Louise Zornoza,
Australia's Therapeutic Goods Administration (TGA) has opened a consultation on proposed changes to the current regulatory framework for the advertising of therapeutic goods to the general public. The TGA noted that it is not proposing any changes relating to the advertising of prescription and certain pharmacist-only medicines to the general public, which will remain prohibited in Australia.
The objectives of the proposed reforms are to:
This consultation expands on the options for advertising reform released in May 2012 that targeted pre-approval arrangements, the complaints handling processes and to the sanctions and penalties that apply to advertising breaches. The deadline for comments on the proposed amendments is 12 July 2013.
Read all Breaking News from RegLink
Tags: Consultation, marketing, australia, advertising